Terms: = Breast cancer AND MITF, WS2A, ENSG00000187098, 4286 AND Treatment
8 results:
1. HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin.
Biondini M; Kiepas A; El-Houjeiri L; Annis MG; Hsu BE; Fortier AM; Morin G; Martina JA; Sirois I; Aguilar-Mahecha A; Gruosso T; McGuirk S; Rose AAN; Tokat UM; Johnson RM; Sahin O; Bareke E; St-Pierre J; Park M; Basik M; Majewski J; Puertollano R; Pause A; Huang S; Keler T; Siegel PM
Oncogene; 2022 Mar; 41(12):1701-1717. PubMed ID: 35110681
[TBL] [Abstract] [Full Text] [Related]
2. Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo.
Elango R; Vishnubalaji R; Manikandan M; Binhamdan SI; Siyal AA; Alshawakir YA; Alfayez M; Aldahmash A; Alajez NM
Sci Rep; 2019 Sep; 9(1):13696. PubMed ID: 31548560
[TBL] [Abstract] [Full Text] [Related]
3. Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options.
Ross JS; Badve S; Wang K; Sheehan CE; Boguniewicz AB; Otto GA; Yelensky R; Lipson D; Ali S; Morosini D; Chliemlecki J; Elvin JA; Miller VA; Stephens PJ
Arch Pathol Lab Med; 2015 May; 139(5):642-9. PubMed ID: 25927147
[TBL] [Abstract] [Full Text] [Related]
4. Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.
Lorenzen S; Riera Knorrenschild J; Haag GM; Pohl M; Thuss-Patience P; Bassermann F; Helbig U; Weißinger F; Schnoy E; Becker K; Stocker G; Rüschoff J; Eisenmenger A; Karapanagiotou-Schenkel I; Lordick F
Eur J Cancer; 2015 Mar; 51(5):569-76. PubMed ID: 25694417
[TBL] [Abstract] [Full Text] [Related]
5. Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers.
Lin DC; Xu L; Ding LW; Sharma A; Liu LZ; Yang H; Tan P; Vadgama J; Karlan BY; Lester J; Urban N; Schummer M; Doan N; Said JW; Sun H; Walsh M; Thomas CJ; Patel P; Yin D; Chan D; Koeffler HP
Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6109-14. PubMed ID: 23536305
[TBL] [Abstract] [Full Text] [Related]
6. mitf-Mdel, a novel melanocyte/melanoma-specific isoform of microphthalmia-associated transcription factor-M, as a candidate biomarker for melanoma.
Wang Y; Radfar S; Liu S; Riker AI; Khong HT
BMC Med; 2010 Feb; 8():14. PubMed ID: 20163701
[TBL] [Abstract] [Full Text] [Related]
7. Expression of melanocyte-related genes in human breast cancer and its implications.
Montel V; Suzuki M; Galloy C; Mose ES; Tarin D
Differentiation; 2009 Dec; 78(5):283-91. PubMed ID: 19699574
[TBL] [Abstract] [Full Text] [Related]
8. [Second tumours in patients with malignant neoplasms of the digestive apparatus. A retrospective study on 2406 cases].
Minni F; Casadei R; Marrano N; Guerra E; Piccoli L; Pagogna S; Rega D
Ann Ital Chir; 2005; 76(5):467-72. PubMed ID: 16696221
[TBL] [Abstract] [Full Text] [Related]
